Cancer is a complex disease with global significance,
necessitating
continuous advancements in diagnostics and treatment. 3D printing
technology has emerged as a revolutionary tool in cancer diagnostics,
offering immense potential in detection and monitoring. Traditional
diagnostic methods have limitations in providing molecular and genetic
tumor information that is crucial for personalized treatment decisions.
Biomarkers have become invaluable in cancer diagnostics, but their
detection often requires specialized facilities and resources. 3D
printing technology enables the fabrication of customized sensor arrays,
enhancing the detection of multiple biomarkers specific to different
types of cancer. These 3D-printed arrays offer improved sensitivity,
allowing the detection of low levels of biomarkers, even in complex
samples. Moreover, their specificity can be fine-tuned, reducing false-positive
and false-negative results. The streamlined and cost-effective fabrication
process of 3D printing makes these sensor arrays accessible, potentially
improving cancer diagnostics on a global scale. By harnessing 3D printing,
researchers and clinicians can enhance early detection, monitor treatment
response, and improve patient outcomes. The integration of 3D printing
in cancer diagnostics holds significant promise for the future of
personalized cancer care.